REGENXBIO Inc.

US$7.62As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:RGNXHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (6.99%)
Div yield —
ROE (113.24%)
Biotechnology
Beta (5Y) 1.23
PE TTM —
TSR TTM (40.33%)
Mkt cap US$503.9M
ROIC (101.25%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$8.76
14.96%
(46.48%)
Hold 8|12|7|11|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.10
0.10
0.10
0.10
14.78%
6.08%
(7.04%)
(4.17%)
Revenue$M
62.98
64.42
63.01
63.47
5.26%
9.36%
3.39%
(0.35%)
Peers (US$503.9M)
Cap (US$)
PE
506.5M
—
Capital
TTM
5Y
10Y
Leveragex
5.217
0.087
0.066
EBIT/Intx
2.097
0.142
0.143
Own earn%
(59.32)
(109.24)
(78.05)
Sh yield%
28.81
12.05
13.92
Owners
Insiders/Inst%
6.27
54.92
Short interest%
4.29
SBC / revenue%
1.55
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
18–24
$1 testx
—
Incr. ROIC%
2